Jayson Rieger

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 44 W. Gay St., Suite 400, West Chester, PA
Signature
/s/ Christopher Hayes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jayson Rieger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. CEO and President, Director Common Stock 883K $2.17M $2.46 Nov 26, 2024 Direct
Verrica Pharmaceuticals Inc. CEO and President, Director Common Stock 2.3K $5.66K $2.46 Nov 22, 2024 By trust
Verrica Pharmaceuticals Inc. CEO and President, Director Common Stock 150 $369 $2.46 Nov 22, 2024 By child
Verrica Pharmaceuticals Inc. CEO and President, Director Employee Stock Option (right to buy) 2M Nov 6, 2024 Direct
Verrica Pharmaceuticals Inc. CEO and President, Director Series A Warrants (right to buy) 140K Nov 22, 2024 Direct
Verrica Pharmaceuticals Inc. CEO and President, Director Series B Warrants (right to buy) 140K Nov 22, 2024 Direct

Insider Reports Filed by Jayson Rieger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Nov 22, 2024 4 $0 4 Nov 26, 2024 CEO and President, Director
VRCA Verrica Pharmaceuticals Inc. Nov 6, 2024 1 $0 4 Nov 6, 2024 CEO and President, Director
VRCA Verrica Pharmaceuticals Inc. Nov 5, 2024 0 $0 3 Nov 6, 2024 CEO and President, Director